Clinical Trials on Primary Cutaneous Vasculitis in Switzerland

Total 1043 results

Hospices Civils de Lyon

Unknown

CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors

Churg-Strauss Syndrome

Switzerland
Novartis Pharmaceuticals

Completed

Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion

Intraocular Inflammation | Retinal Vascular Occlusion

Switzerland
Hospices Civils de Lyon

Unknown

CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors

Microscopic Polyangiitis | Polyarteritis Nodosa

Switzerland
University of Zurich

Completed

Livedoid Vasculopathy: Strong Association With Smoking, Weak Association With Thrombophilia

Livedoid Vasculitis

Switzerland
Insel Gruppe AG, University Hospital Bern
Paul Scherrer Institut, Center for Proton Therapy

Not yet recruiting

A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis (CRAFT)

Giant Cell Arteritis

Switzerland
University Hospital Inselspital, Berne
Roche Pharma AG; University of Bern

Completed

Tocilizumab for Patients With Giant Cell Arteritis

Giant Cell Arteritis

Switzerland
University Hospital Inselspital, Berne

Completed

Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab (GUSTO)

Giant Cell Arteritis

Switzerland
Onxeo

Completed

A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma

Cutaneous T-cell Lymphoma

Austria, France, Germany, Switzerland
University Hospital, Basel, Switzerland
Novartis; Schweizerische Stiftung für die Erforschung der Muskelkrankheiten

Recruiting

Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis

Polymyalgia Rheumatica (PMR) | Giant Cell Arteritis (GCA)

Switzerland
Hoffmann-La Roche

Completed

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).

Giant Cell Arteritis

Switzerland
Biogen

Enrolling by invitation

A Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of BIIB059 (Litifilimab) in Adults With Active Subacute Cutaneous Lupus Erythematosus (CLE) and/or Chronic CLE With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST LTE)

Subacute Cutaneous Lupus Erythematosus | Chronic Cutaneous Lupus Erythematosus

Spain, United States, France, Switzerland, Sweden
Amgen

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants

Vasculitis | Systemic Lupus Erythematosus (SLE)

Switzerland
University of Zurich

Unknown

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases (NEUTROGENE)

Pustular Psoriasis | Erosive Pustular Dermatosis of the Scalp | Behcet's Disease | Dermatitis Herpetiformis | Pyoderma Gangrenosum | Linear IgA Bullous Dermatosis | Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue | Sweet's Syndrome | Bowel-associated Dermatosis-arthritis Syndrome | Acute Generalized Exanthematous Pustulosis and other conditions

Switzerland
University Hospital, Basel, Switzerland

Terminated

Venous Vascularization and Inflammation on Contrast-enhanced Ultrasound (CEUS) in Patients With Thrombosis

Thrombosis

Switzerland
University Hospital, Basel, Switzerland
Swiss Foundation for the Study of Muscular Diseases

Completed

Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course

Giant Cell Arteritis | Large Vessel Giant Cell Arteriitis

Switzerland
University Hospital Inselspital, Berne

Withdrawn

Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars

Lupus Erythematosus, Cutaneous

Switzerland
Pfizer

Completed

Use of 852A in Metastatic Cutaneous Melanoma.

Melanoma | Unresectable Metatstatic Cutaneous Melanoma

Switzerland, Germany, France
ChemoCentryx

Completed

A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE)

ANCA-Associated Vasculitis

United States, Australia, Belgium, Canada, France, Italy, Japan, Netherlands, Spain, United Kingdom, Austria, Czechia, Denmark, Germany, Hungary, Ireland, New Zealand, Norway, Sweden, Switzerland
Innovent Biologics (Suzhou) Co. Ltd.
Innovent Biologics (USA), Inc.

Withdrawn

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

Metastatic Cutaneous Melanoma | Unresectable Cutaneous Melanoma

United States, Germany, France, Australia, Spain, Switzerland, United Kingdom
Millennium Pharmaceuticals, Inc.
Seagen Inc.

Completed

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) (ALCANZA)

Mycosis Fungoides | Cutaneous T-Cell Lymphoma | Primary Cutaneous Anaplastic Large Cell Lymphoma

United States, France, Italy, United Kingdom, Spain, Switzerland, Brazil, Austria, Belgium, Germany, Poland, Australia
Centre Hospitalier Universitaire Vaudois

Recruiting

FLASH Radiotherapy for Skin Cancer (LANCE)

Basal Cell Carcinoma | Cutaneous Squamous Cell Carcinoma

Switzerland
University of Zurich

Completed

T-VEC in Non-melanoma Skin Cancer (20139157 T-VEC)

Merkel Cell Carcinoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Non-melanoma Skin Cancer | Cutaneous Lymphoma

Switzerland
European Organisation for Research and Treatment...
Mallinckrodt

Withdrawn

Study of Photopheresis in the Treatment of Erythrodermic MF and SS (PROMPT)

Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary Syndrome

Switzerland
Human Genome Sciences Inc., a GSK Company
GlaxoSmithKline

Completed

Belimumab in Remission of VASculitis (BREVAS)

Vasculitis

United States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
European Organisation for Research and Treatment...
Hoffmann-La Roche

Terminated

PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL) (PARCT)

Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary Syndrome

Spain, Switzerland
Biogen

Recruiting

A Study to Assess the Efficacy and Safety of BIIB059 (Litifilimab) in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)

Subacute Cutaneous Lupus Erythematosus | Chronic Cutaneous Lupus Erythematosus

United States, Italy, Korea, Republic of, Taiwan, Argentina, Chile, Spain, Canada, Serbia, France, Germany, Japan, Brazil, United Kingdom, Bulgaria, Portugal, Switzerland, Philippines, Saudi Arabia, Sweden, Mexico, Poland, Hungary, Puerto... and more
Zurich University of Applied Sciences

Completed

Identification of Endometriosis and Migraine Criteria in Women With the Comorbidity of Both Conditions in Comparison With Women Who Only Suffer From Endometriosis - A Pilot Study

Migraine | Endometriosis

Switzerland
University Hospital, Basel, Switzerland

Completed

Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature

Primary Vascular Dysregulation

Switzerland
BioCryst Pharmaceuticals

Completed

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

Cutaneous T-cell Lymphoma (CTCL),

United States, Australia, Germany, Italy, Spain, France, Austria, Finland, Switzerland, United Kingdom
InflaRx GmbH

Completed

Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis. (IXchange)

Granulomatosis With Polyangiitis (GPA) | Microscopic Polyangiitis (MPA)

Germany, Russian Federation, Belgium, France, Spain, Czechia, Italy, Netherlands, Sweden, Switzerland, United Kingdom
University Hospital Inselspital, Berne

Completed

The Crosstalk Between Calcium-sensing Receptor Signaling and Endocannabinoid System in Primary Hyperparathyroidism (Targeting CaSR)

Primary Hyperparathyroidism

Switzerland
Insel Gruppe AG, University Hospital Bern
University of Bern

Recruiting

STREAM Trial - Biomarker (STREAM-Bio)

Statin Treatment for Primary Prevention

Switzerland
Novartis Pharmaceuticals

Recruiting

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR

Giant Cell Arteritis | Polymyalgia Rheumatica

United States, Spain, Switzerland
Centre Hospitalier Universitaire Vaudois
The Novartis Foundation

Recruiting

Primary Hyperparathyroidism and Gut Microbiota (HYPOGEUM)

Hyperparathyroidism, Primary

Switzerland
University of Bern
Swiss Federal Institute of Technology

Completed

Efficacy of Taiji Training as a Program for Stress Prevention

Stress | Primary Prevention | Adult | Tai ji

Switzerland
Philogen S.p.A.

Recruiting

Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients (DUNCAN)

Carcinoma, Basal Cell | Carcinoma, Cutaneous Squamous Cell

Germany, Poland, Switzerland
Mundipharma Research Limited

Active, not recruiting

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

Multiple Myeloma | Hodgkin's Lymphoma | Hematological Malignancies | Cutaneous T Cell Lymphoma

France, United States, Netherlands, Spain, Switzerland, Germany, Italy
Kantonsspital Graubuenden
Klinik Hirslanden, Zurich

Completed

Secondary Cancer Risk After Radiation Therapy for Rectal Cancer

Neoplasms, Second Primary

Switzerland
University Hospital Inselspital, Berne

Terminated

Maturation of Follicles After Transplantation of Ovarian Tissue Into the Pelvic Wall and the Ovary (Ovartrans)

Infertility | Ovarian Failure, Premature

Switzerland
University of Zurich
University Hospital, Geneva; University of Bern; Swiss Tropical & Public Health... and other collaborators

Completed

Immunogenicity and Safety of Vaccinations in Immunocompromised Persons

Arthritis, Rheumatoid | Vasculitis | Spondylarthritis

Switzerland
University of Zurich

Recruiting

Pathophysiology of Inborn Immunodeficiencies

Primary Immune Deficiency Disorder

Switzerland
University of Zurich

Recruiting

Identification of New Inborn Errors of Immunity

Primary Immune Deficiency Disorder

Switzerland
University Hospital, Basel, Switzerland

Completed

Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study) (GOLD)

Primary Polydipsia

Switzerland
University of Zurich
PD Dr. med. Verena Geissbühler; Prof. pharm. Ursula von Mandach; Dr. med. David... and other collaborators

Terminated

Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder (BryoSoliP)

Overactive Bladder | Urge Urinary Incontinence

Switzerland
Max Zeller Soehne AG

Completed

Efficacy Study of Zeller Entspannung Film Coated Tablets on Acute Stress

The Primary Condition Studied for This Trial is Acute Stress

Switzerland
University of Zurich
University Hospital Tuebingen; Salzburger Landeskliniken

Completed

Multisystem Cell Therapy for Improvement of Urinary Continence (MUSIC)

Urinary Stress Incontinence

Switzerland
Insel Gruppe AG, University Hospital Bern
University of Bern

Recruiting

STREAM Trial - Subclinical Atherosclerosis (STREAM-SubATS)

Statin Treatment for Primary Prevention

Switzerland
Oxys Medical AG

Unknown

Prevention of Catheter Associated Lower Urinary Infections Using the Oxys Indwelling Catheter

Urinary Infections

Switzerland
European Organisation for Research and Treatment...

Active, not recruiting

Minimal SN Tumor Burden (Minitub)

Cutaneous Melanoma

France, Italy, Switzerland, Belgium, Netherlands, Germany, Poland, Slovenia, United Kingdom, Spain
University Hospital Inselspital, Berne

Completed

Effects of Thoracic Epidural Anesthesia on Lower Urinary Tract Function

Urodynamics | Acute Urinary Retention

Switzerland

Clinical Trials on Primary Cutaneous Vasculitis in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations